| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |